Management to Provide Update on Strategic Acquisitions, Financing, Growth Initiatives & Spin Out of NuGenerex Immuno-Oncology

- Potential Acquisition of 13 Hospitals as well as Hospital IT and Management company

- Potential Acquisition of World Class Nutraceutical Company

- Potential Acquisition of Home Delivered Medically Approved Foods Business for Chronic Care of diabetes, cancer, cardiovascular, and rheumatoid arthritis patients

- Acquisition of Direct to Patient End to End Pharmacy Business

- Update on Fuse Medical Acquisition

- Update on Medisource Partners Acquisition

- Update on Pantheon Acquisition

- Update on NuGenerex Immuno-Oncology (NGIO) dividend and Go Public Strategy

- Acquisition plans for NGIO Merger with Company with Synergistic Platforms

- NGIO Acquisition of World Class IP

- Discussion of financial and legal issues